Bigul

HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release on the Financial Results of the Company for the quarter and nine months ended December 31, 2021
10-02-2022
Bigul

HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Investor Presentation

The Presentation on the Financial Results of the Company for the quarter and nine months ended December 31, 2021.
10-02-2022
Bigul

HealthCare Global Enterprises Ltd - 539787 - Results-Financial Results For Dec 31, 2021

The Board of Directors of the Company ('Board'), at their meeting held on this day, February 10, 2022, inter alia, has considered and approved the following agenda: Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2021.
10-02-2022
Bigul

HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Further to the intimation submitted to Stock Exchanges dated January 24, 2022 with respect to meeting of the Board of Directors of the Company to be held on Thursday, February 10, 2022, interalia to consider, approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2021 ('Unaudited Financial Results'), we would like to inform you that, an Earnings Conference Call has been scheduled on Thursday, February 10, 2022, at 06.00 p.m. (IST), to discuss the Unaudited Financial Results of the Company.
05-02-2022

114 genetic variants associated with oral cancer identified, reveals study

In what is claimed to be path-breaking research, the city-based government institute, along with HCG, has identified 114 genetic variants which cause oral cancer in humans. The study has revealed key genetic signatures also that can predict survival in oral cancer patients with over 90 percent accuracy. Karnataka Minister for IT/BT and S&T C N Ashwath Narayan said, the research was conducted jointly by IBAB (Institute of Bioinformatics and Applied Biotechnology), an institute set up by Department of IT/BT, and research doctors from HCG, using state-of-the-art genomics facility located at IBAB. The study made extensive use of advanced machine learning and bio-informatics, he was quoted as saying by his office in a press release. Though the oral cancer is one of the most common in the country (40 percent of all cancer cases), this was the first time such an extensive study had been carried out relating to this. The data obtained in the research has been compared with western...
04-02-2022
Bigul

HealthCare Global Enterprises Ltd - 539787 - Board Meeting Intimation for Considering, Approving And Taking On Record The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2021.

Healthcare Global Enterprises Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2022 ,inter alia, to consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2021.
24-01-2022
Bigul

HealthCare Global Enterprises Ltd - 539787 - Statement Of Investor Complaints For The Quarter Ended December 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sunu ManuelDesignation :- Company Secretary and Compliance Officer
19-01-2022
Bigul

HealthCare Global Enterprises Ltd - 539787 - Shareholding for the Period Ended December 31, 2021

HealthCare Global Enterprises Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here
18-01-2022
Bigul

HealthCare Global Enterprises Ltd - 539787 - Shareholding for the Period Ended December 06, 2021

HealthCare Global Enterprises Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 06, 2021. For more details, kindly Click here
24-12-2021
Bigul

HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Change in Directorate

Initmation regarding resignation of Mr Sudhakar Rao (DIN: 00267211) Independent Director of the Company
18-12-2021
Next Page
Close

Let's Open Free Demat Account